Development of a low-seroprevalence, αvβ6 integrin-selective virotherapy based on human adenovirus type 10
Titel:
Development of a low-seroprevalence, αvβ6 integrin-selective virotherapy based on human adenovirus type 10
Auteur:
Bates, Emily A. Davies, James A. Váňová, Jana Nestić, Davor Meniel, Valerie S. Koushyar, Sarah Cunliffe, Tabitha G. Mundy, Rosie M. Moses, Elise Uusi-Kerttula, Hanni K. Baker, Alexander T. Cole, David K. Majhen, Dragomira Rizkallah, Pierre J. Phesse, Toby Chester, John D. Parker, Alan L.